Evidence map›Paper›PMID 40666138›Full record

ReviewAntimicrobial stewardship & healthcare epidemiology : ASHE2025

Uniting disciplines against antimicrobial resistance (AMR): highlights from a multidisciplinary inaugural AMR summit.

Brittany Rodriguez, Andrea M Prinzi, Brandon K Hill, Robert Tibbetts, Heinz Salazar, David McAdams, Awilda M Rivera-Acosta, Minkey Wungwattana, Denver T Niles, Suzane Silbert

Erratum issuedAbstract readReview
In one paragraph

Review in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Brittany RodriguezDepartment of Pharmacy Services, Texas Children's Hospital, Houston, TX, USA.ORCID https://orcid.org/0009-0009-8737-4227
Andrea M PrinziUS Medical Affairs, bioMérieux, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0003-2949-5484
Brandon K HillUS Medical Affairs, bioMérieux, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0001-6509-9302
Robert TibbettsMicrobiology, Henry Ford Health, Detroit, MI, USA.
Heinz SalazarMicrobiology, Tampa General Hospital, Tampa, FL, USA.
David McAdamsFuqua School of Business and Economics Department, Duke University, Durham, NC, USA.
Awilda M Rivera-AcostaDepartment of Pathology-Microbiology, Texas Children's Hospital, Houston, TX, USA.
Minkey WungwattanaUS Medical Affairs, bioMérieux, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0002-0264-7831
Denver T NilesBaylor College of Medicine, Department of Pathology, Houston, TX.ORCID https://orcid.org/0000-0001-7452-4366
Suzane SilbertMicrobiology, Tampa General Hospital, Tampa, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a significant global health threat, projected to cause 10 million deaths annually by 2050. Addressing AMR requires a coordinated, multidisciplinary approach encompassing infectious disease (ID) clinicians, pharmacists, microbiologists, infection preventionists, and policymakers. The inaugural AMR Summit, hosted by bioMérieux in collaboration with Tampa General Hospital and the University of South Florida Morsani College of Medicine in November 2024, convened experts from various fields to explore innovative strategies for combating AMR. Key topics discussed included the role of multidisciplinary teams in antimicrobial stewardship programs, advancements in rapid diagnostic tests and antimicrobial susceptibility testing, the application of implementation science in AMR, and the integration of next-generation sequencing in ID diagnostics. The summit underscored the importance of diagnostic innovation, interdisciplinary collaboration, policy, advocacy, and public engagement in advancing efforts against AMR.

Identifiers

PMID40666138
PMCPMC12260250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.